Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Expert Rev Endocrinol Metab ; 14(3): 193-202, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-31023107

RESUMEN

INTRODUCTION: Optimising bone health might reduce the burden of both fractures in childhood and fragility fractures in later life. A number of maternal dietary and non-dietary factors have been identified that might influence offspring bone health and represent targets for intervention. AREAS COVERED: This article will outline the accrual of bone mineral throughout the life course and how observational and intervention studies have shown that maternal diet, in particular maternal calcium and 25-hydroxyvitamin D [25(OH)D] status, and lifestyle are associated with offspring bone mineralization. Studies examining the effects of maternal micronutrient supplementation on offspring bone mineral density (BMD) will also be discussed. EXPERT COMMENTARY: There is a wealth of observational evidence relating maternal diet to offspring BMD. However, high quality randomized controlled trials, such as the ongoing MAVIDOS study, are needed before these findings can be definitively translated into public health advice.


Asunto(s)
Enfermedades del Desarrollo Óseo/prevención & control , Calcificación Fisiológica , Fenómenos Fisiologicos Nutricionales Maternos , Lesiones Prenatales/prevención & control , Densidad Ósea , Enfermedades del Desarrollo Óseo/dietoterapia , Calcio de la Dieta/metabolismo , Ensayos Clínicos como Asunto , Suplementos Dietéticos , Femenino , Humanos , Salud Materna , Estudios Observacionales como Asunto , Embarazo , Lesiones Prenatales/dietoterapia , Vitamina D/análogos & derivados , Vitamina D/metabolismo , Deficiencia de Vitamina D/prevención & control
2.
J Nutr Biochem ; 25(6): 623-33, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24746838

RESUMEN

Omega-3 fatty acids (FAs) are essential nutritional components that must be obtained from foods. Increasing evidence validate that omega-3 FAs are beneficial for bone health, and several mechanisms have been suggested to mediate their effects on bone, including alterations in calcium absorption and urinary calcium loss, prostaglandin synthesis, lipid oxidation, osteoblast formation and inhibition of osteoclastogenesis. However, to date, there is scant information regarding the effect of omega-3 FAs on the developing skeleton during the rapid growth phase. In this study we aim to evaluate the effect of exposure to high levels of omega-3 FAs on bone development and quality during prenatal and early postnatal period. For this purpose, we used the fat-1 transgenic mice that have the ability to convert omega-6 to omega-3 fatty acids and the ATDC5 chondrogenic cell line as models. We show that exposure to high concentrations of omega-3 FAs at a young age accelerates bone growth through alterations of the growth plate, associated with increased chondrocyte proliferation and differentiation. We further propose that those effects are mediated by the receptors G-protein coupled receptor 120 (GPR120) and hepatic nuclear factor 4α, which are expressed by chondrocytes in culture. Additionally, using a combined study on the structural and mechanical bone parameters, we show that high omega-3 levels contribute to superior trabecular and cortical structure, as well as to stiffer bones and improved bone quality. Most interestingly, the fat-1 model allowed us to demonstrate the role of maternal high omega-3 concentration on bone growth during the gestation and postnatal period.


Asunto(s)
Desarrollo Óseo , Enfermedades del Desarrollo Óseo/prevención & control , Huesos/patología , Ácidos Grasos Omega-3/biosíntesis , Osteogénesis , Animales , Densidad Ósea , Enfermedades del Desarrollo Óseo/enzimología , Enfermedades del Desarrollo Óseo/metabolismo , Enfermedades del Desarrollo Óseo/patología , Huesos/citología , Huesos/metabolismo , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Línea Celular , Proliferación Celular , Condrocitos/citología , Condrocitos/metabolismo , Condrocitos/patología , Ácido Graso Desaturasas/genética , Ácido Graso Desaturasas/metabolismo , Ácidos Grasos Omega-3/uso terapéutico , Femenino , Factor Nuclear 4 del Hepatocito/agonistas , Factor Nuclear 4 del Hepatocito/metabolismo , Heterocigoto , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Receptores Acoplados a Proteínas G/agonistas , Receptores Acoplados a Proteínas G/metabolismo , Caracteres Sexuales , Organismos Libres de Patógenos Específicos
3.
Rev Invest Clin ; 65(1): 39-51, 2013.
Artículo en Español | MEDLINE | ID: mdl-23745443

RESUMEN

INTRODUCTION: Propranolol (P) treatment exerts a preventive effect against the detrimental consequences to bone status in mildly chronically food-restricted growing rats (NGR) by an increment in cortical bone and by improving its spatial distribution. OBJECTIVE: To study the effect of beta-blocker on operational mechanism of bone mechanostat in an animal model of nutritional stress. MATERIAL AND METHODS: Weanling male Wistar rats were randomly assigned to four groups: control (C), C + P (CP), NGR and NGR + P (NGRP). C and CP rats were fed freely with the standard diet. NGR and NGRP rats received, for 4 weeks, 80% of the amount of food consumed by C and CP respectively, the previous day, corrected by body weight. Propranolol (7 mg/kg/day) was injected ip 5 days per week, for four weeks in CP and NGRP rats. C and NGR received saline injections at an identical dosage regimen. Body weight and length were determined during the experimental period. Dietary intake was registered daily. Animals were sacrificed after 4 weeks of food restriction. Immediately, cuadriceps, femur and tibiae from each animal were dissected and weighed, and histomorphometric and mechanical studies were performed. Serum a-CTX, osteocalcin, intact PTH, calcium and phosphorous were determined. Body protein (% prot) was measured in all groups. RESULTS: Food restriction induced detrimental effects on body and femoral growth, load-bearing capacity (Wf), % prot and cuadriceps weight in NGR us. C (p < 0.01). beta-blocker did not modify anthropometric and bone morphometric parameters in NGRP and CP us. NGR and C, respectively (p > 0.05). However, Wf NGRP vs. NGR was significantly higher (p < 0.01). alpha-CTX was significantly higher in NGR vs. C (p < 0.01). No significant differences were observed in alpha-CTX levels between CP, NGRP and C (p > 0.05). Serum osteocalcin, intact PTH, calcium and phospho- rous showed no significant difference between groups (p > 0.05). CONCLUSION: These results suggest that modeling increase in bone mass and strength in NGRP rats could be due to an anticatabolic interaction of the beta-blocker propranolol on operational mechanism of bone mechanostat in an animal model of nutritional stress.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Enfermedades del Desarrollo Óseo/prevención & control , Privación de Alimentos/fisiología , Trastornos del Crecimiento/prevención & control , Desnutrición/fisiopatología , Propranolol/uso terapéutico , Antagonistas Adrenérgicos beta/farmacología , Animales , Biomarcadores , Peso Corporal/efectos de los fármacos , Enfermedades del Desarrollo Óseo/sangre , Enfermedades del Desarrollo Óseo/etiología , Enfermedades del Desarrollo Óseo/patología , Remodelación Ósea/efectos de los fármacos , Colágeno Tipo I/sangre , Módulo de Elasticidad/efectos de los fármacos , Fémur/efectos de los fármacos , Fémur/patología , Trastornos del Crecimiento/sangre , Trastornos del Crecimiento/etiología , Trastornos del Crecimiento/patología , Masculino , Desnutrición/tratamiento farmacológico , Minerales/sangre , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Tamaño de los Órganos/efectos de los fármacos , Hormona Paratiroidea/sangre , Péptidos/sangre , Propranolol/farmacología , Proteínas/análisis , Distribución Aleatoria , Ratas , Ratas Wistar , Soporte de Peso
4.
Poult Sci ; 57(3): 757-62, 1978 May.
Artículo en Inglés | MEDLINE | ID: mdl-566919

RESUMEN

Studies were conducted into the etiology of leg abnormalities noted in chicks fed high tannin sorghum grain diets. These anomalies were characterized by a bowing of the legs with a swelling of the hock joints. The incidence of these leg problems was found to be markedly higher when the amino acids in the diet provided by soybean meal were replaced by crystalline amino acids. Supplemental vitamins and minerals had no alleviating effect on the leg problem. Bone mineralization was apparently not influenced by tannins as demonstrated by similar bone ash values for chicks fed high or low tannin sorghums. A possible alteration caused by tannin in the organic matrix of bone is discussed. High tannin sorghum depressed chick growth and feed conversion when compared with low tannin sorghum in both sorghum-soybean meal and sorghum-amino acid rations. This growth depression was overcome by supplementing the high tannin sorghum-soybean meal diet with .15% DL-methionine, but no growth response was observed from a similar supplementation of a high tannin sorghum-amino acid diet.


Asunto(s)
Alimentación Animal/efectos adversos , Enfermedades del Desarrollo Óseo/veterinaria , Pollos , Grano Comestible/efectos adversos , Enfermedades de las Aves de Corral/etiología , Taninos/efectos adversos , Aminoácidos/efectos adversos , Animales , Enfermedades del Desarrollo Óseo/etiología , Enfermedades del Desarrollo Óseo/prevención & control , Fémur/metabolismo , Masculino , Metionina/uso terapéutico , Enfermedades de las Aves de Corral/prevención & control , Glycine max
5.
Pediatr Res ; 9(7): 568-75, 1975 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1161345

RESUMEN

Infants of two groups, one of 16, one of 14 infants, who weighed less than 1.3 kg at birth (mean 1.01 +/- 0.05 kg), were studied from age 14 days until they reached 1.8 kg body weight. Infants were pair-matched for gestational age and birth weight and one member was randomly allocated to two treatment groups. Infants in group A received no calcium supplement and those in group B received calcium lactate, 800 mg/kg/24 hr hr, in divided doses with each feed. All were fed "Improved" SMA, 200 ml/kg/24 hr, 160 cal/kg/24 hr, and were given a multivitamin preparation containing 500 IU vitamin D2/dose. The infants' weekly length gain did not differ between groups (1.08 +/- 0.04 cm/week vs 1.11 +/- 0.04 cm/week; mean +/- SEM). Mean weight and head cercumference increments also were similar (group A, 163 +/- 6 g/week; 1.12 +/- 0.03 cm/week; group B, 170 +/- 6 g/week and 1.18 +/- 0.03 cm/week). An increase in blood pH from 7.33 +/- 0.01 to 7.41 +/- 0.01 (P less than 0.01) in group A babies was associated with a decrease in PCO2 from 44.2 +/- 1.0 to 38.9 +/- 1.4 mm Hg. Values remained unchanged with age in group B babies...


Asunto(s)
Calcio/uso terapéutico , Fenómenos Fisiológicos Nutricionales del Lactante , Recien Nacido Prematuro , Minerales/metabolismo , Peso al Nacer , Estatura , Peso Corporal , Enfermedades del Desarrollo Óseo/prevención & control , Calcio/orina , Cationes Bivalentes , Femenino , Crecimiento , Humanos , Lactante , Recién Nacido , Rodilla/diagnóstico por imagen , Lactatos/uso terapéutico , Magnesio/orina , Osteoporosis/diagnóstico por imagen , Embarazo , Radiografía , Tibia/diagnóstico por imagen , Vitamina D/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA